Ignite Creation Date:
2024-05-06 @ 6:54 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05824559
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-27
First Post:
2023-03-22
Brief Title:
ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer
Sponsor:
MEI Pharma Inc
Organization:
MEI Pharma Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-22
First Submit QC Date:
April 20 2023
Study First Post Date:
2023-04-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-26
Last Update Post Date:
2024-06-27
Last Update Post Date Type:
ACTUAL